AIDS drug funding
Executive Summary
Supplemental appropriations bill (HR 1827), approved by House and Senate conferees June 27, provides $30 mil. for AZT "or any other drug which proves to prolong the life of a person with AIDS and related complexes." Low-income individuals not covered by Medicaid or third-party providers would be eligible.
Supplemental appropriations bill (HR 1827), approved by House and
Senate conferees June 27, provides $30 mil. for AZT "or any other
drug which proves to prolong the life of a person with AIDS and
related complexes." Low-income individuals not covered by Medicaid
or third-party providers would be eligible. |